Sign in
4

Changes in Ownership

Pyxis Oncology, Inc. Filed Acc 0000950170-25-048893

Options or other derivatives

  • CFO & COO acquired 414,163 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Connealy Pamela Ann · CFO & COO

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +414,163 $0.98 $405,880 414,163 D
Loading xslF345X05/ownership.xml…